depression

Kendis Gibson, a familiar face in U.S. TV news, is sharing a deeply personal journey in his new book, “Five Trips.” As Variety reported, the memoir offers readers an unflinching look at Gibson's career struggles, mental health battles and his path to healing through psychedelic...

A massive, "everything bubble" will burst in 2025, resulting in a crash and possibly a depression. That’s according to renowned economist Harry Dent. The scenario, while bleak, will present a potentially massive Bitcoin (CRYPTO: BTC) buying opportunity.  “I can tell you one thing:...

A new study conducted by Monash University researchers offers promising insights into how psilocybin, a compound found in magic mushrooms, may help treat major depression. As Medicalxpress reported, in a groundbreaking experiment, rats treated with psilocybin demonstrated increased optimism and...

Researchers found that psilocybin, the active compound in magic mushrooms, performs just as well as the commonly prescribed antidepressant escitalopram (Lexapro) in reducing depression symptoms, with additional benefits for patients' overall well-being. The findings, published on September 21 in...

Meta Platforms Inc’s (NASDAQ:META) Instagram has initiated a pilot program in collaboration with the Center for Open Science (COS), permitting selected researchers to access its data. This move aims to investigate the potential impact of social media on the mental well-being of teens and...

"Tremendous Excitement" Around Psychedelic Medicine, Says Top Federal Drug Official There is "tremendous excitement" about the therapeutic potential of psychedelics, says National Institute on Drug Abuse (NIDA) Director Nora Volkow. However, this top federal drug official emphasized that while...

Robert Kiyosaki, the author of the best-selling book “Rich Dad Poor Dad,” believes the U.S. economy is definitely in a state of depression. What Happened: On Friday, Kiyosaki took to X, to express his view on the state of the U.S. economy. He stated that the economy was in a state of...

Businessman and author Robert Kiyosaki yet again warned of an impending economic crash, adding that it may actually “turn into a depression.” What Happened: Kiyosaki, known for his self-published personal finance book series “Rich Dad Poor Dad,” in a post on X,...

This article was originally published on Psychedelic Spotlight and appears here with permission. Australia’s approval of MDMA and psilocybin-assisted therapy may be what the U.S. regulators need to expedite the approval process in the States. On Saturday, July 1, 2023, Australia officially...

The U.S. Preventive Services Task Force (USPSTF), an advisory panel, has reaffirmed its recommendation for screening most adults for major depression but has not advised broad screening for suicide risk, despite rising suicide rates, STAT News reports. Depression Screening Recommended, Suicide...

This article was originally published on Cannabis.net and appears here with permission. Depression is a pervasive mental health issue that affects millions of people worldwide. It's a complex and debilitating condition that can manifest in various ways, including persistent feelings of sadness...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. As the search for effective treatments for depression continues, researchers have begun to revisit LSD as a treatment for depression. Emerging evidence suggests that LSD may offer a...

Psychedelics biotech company Gilgamesh Pharmaceuticals announced the closing of a $39 million Series B financing round led by Prime Movers Lab and joined by Alumni Ventures, Palo Santo, Negev Capital, Route 66, JLS Fund, Satori Capital and Gron Ventures.  The new funding, which adds to the $27...

Canadian-based psychedelics biopharma company Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) has signed an investigator-initiated clinical trial agreement with Yale University -a recurring type of alliance within the psychedelics space- for the study of multiple intravenous (IV) doses of DMT for the...

(Part three of a four-part series) As for ketamine-assisted therapy, biotech psychedelics company Awakn Life Sciences (OTC: AWAKNF) offers two distinct protocols. One is called KARE (Ketamine in the Reduction of Alcoholic Relapse) and is specific to alcohol use disorder, while the other, KAP (...